Two‐year results of a low‐dose drug‐coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first‐in‐human study

Publisher： John Wiley & Sons Inc

E-ISSN： 1522-726x|86|2|278-286

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.86, Iss.2, 2015-08, pp. : 278-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 3, 2018-02 ,pp. : 497-504

John Wiley & Sons Inc

Access to resources Recommend Favorite

A universal drug delivery catheter for the treatment of infrapopliteal arterial disease: Results from the multi‐center first‐in‐human study

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 2, 2018-02 ,pp. : 296-301

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two‐year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 370-380

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two‐year results from a randomized clinical trial of revascularization in patients with intermittent claudication

By  

BRITISH JOURNAL OF SURGERY, Vol. 103, Iss. 10, 2016-09 ,pp. : 1290-1299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug‐coated balloon treatment of coronary artery disease: A position paper of the Italian Society of Interventional Cardiology

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 83, Iss. 3, 2014-02 ,pp. : 427-435

John Wiley & Sons Inc

Access to resources Recommend Favorite